Dr. Tawbi is Professor of Melanoma Medical Oncology, Investigational Cancer Therapeutics, Deputy Chair and Director of Clinical Research and Early Drug Development at the Department of Melanoma Medical Oncology of the University of Texas MD Anderson Cancer Center. He is a co-founder and Co-Director of the MD Anderson Brain Metastasis Clinic. Dr. Tawbi obtained his MD in 2001 from the American University of Beirut, and completed his training in Internal Medicine, Hematology/Oncology, and obtained his PhD in Clinical and Translational Research at the University of Pittsburgh. He has designed and conducted many Phase I and II clinical trials in melanoma and sarcoma. Dr. Tawbi is nationally and internationally recognized as a leader in melanoma and immunotherapy drug development. He currently serves as Vice-Chair of the SWOG Melanoma Committee, Co-Chair of the STIC Immunotherapy Resistance Committee, and an active member of SITC, the Society for Melanoma Research, AACR, ESMO, and ASCO.
Collaborating PI
Hussein Tawbi, PhD
MD Anderson Cancer Center at the University of Texas
Dr. Tawbi is Professor of Melanoma Medical Oncology, Investigational Cancer Therapeutics, Deputy Chair and Director of Clinical Research and Early Drug Development at the Department of Melanoma Medical Oncology of the University of Texas MD Anderson Cancer Center. He is a co-founder and Co-Director of the MD Anderson Brain Metastasis Clinic. Dr. Tawbi obtained his MD in 2001 from the American University of Beirut, and completed his training in Internal Medicine, Hematology/Oncology, and obtained his PhD in Clinical and Translational Research at the University of Pittsburgh. He has designed and conducted many Phase I and II clinical trials in melanoma and sarcoma. Dr. Tawbi is nationally and internationally recognized as a leader in melanoma and immunotherapy drug development. He currently serves as Vice-Chair of the SWOG Melanoma Committee, Co-Chair of the STIC Immunotherapy Resistance Committee, and an active member of SITC, the Society for Melanoma Research, AACR, ESMO, and ASCO.
